Singapore markets open in 28 minutes

Kiniksa Pharmaceuticals, Ltd. (KNSA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
20.19-0.07 (-0.35%)
At close: 04:00PM EDT
20.88 +0.69 (+3.42%)
After hours: 06:38PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
8,650
14,084
183,363
-157,924
-161,381
Depreciation & amortisation
2,211
2,341
2,402
2,355
2,405
Deferred income taxes
-30,500
-33,788
-185,495
11
4,361
Stock-based compensation
28,240
27,149
25,120
25,173
20,875
Change in working capital
9,668
1,350
-22,575
689
-4,315
Accounts receivable
-8,571
-8,606
-8,675
-3,910
0
Inventory
-3,853
-9,523
-17,924
-3,675
0
Accounts payable
4,193
347
6,031
1,366
-4,969
Other working capital
21,365
13,171
5,702
-146,713
-136,815
Other non-cash items
2,992
3,054
3,041
2,631
1,400
Net cash provided by operating activities
21,555
13,301
5,807
-126,298
-136,532
Cash flows from investing activities
Investments in property, plant and equipment
-190
-130
-105
-20,415
-283
Purchases of investments
-188,313
-204,933
-135,864
-157,250
-430,211
Sales/maturities of investments
222,390
175,506
127,800
306,300
407,050
Net cash used for investing activities
33,887
-29,557
-8,078
128,635
-23,444
Cash flows from financing activities
Common stock issued
-
-
3,417
0
228,222
Common stock repurchased
-2,167
-2,206
-901
0
0
Other financing activities
-
-
-
-
-1,136
Net cash used provided by (used for) financing activities
5,018
1,495
2,516
5,885
227,086
Net change in cash
60,460
-14,761
245
8,222
67,110
Cash at beginning of period
80,618
122,715
122,470
114,248
47,138
Cash at end of period
141,078
107,954
122,715
122,470
114,248
Free cash flow
Operating cash flow
21,555
13,301
5,807
-126,298
-136,532
Capital expenditure
-190
-130
-105
-20,415
-283
Free cash flow
21,365
13,171
5,702
-146,713
-136,815